Universal Technical Institute
UTI NYSE Education Services Financials FY2016βFY2025
Universal Technical Institute's revenue rose 14.1% to $836 million in fiscal 2025. Its operating margin was 10.0%, up from 8.0% a year earlier. Free cash flow was $55 million, down 10.1%. The diluted share count rose 9.4%.
What Universal Technical Institute does
No business description yet.
- Legal name
- UNIVERSAL TECHNICAL INSTITUTE, INC
- Fiscal year ends
- September 30, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001261654-25-000025
0001261654
Revenue and margins
Universal Technical Institute had $836M of revenue in fiscal 2025, up 14.1% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $55.4M in fiscal 2025, 6.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Universal Technical Institute returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 9.4%.
Value Universal Technical Institute yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $36.5M and divides by 55.6M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 35.8x Β· peers 16.9x Β· sector 17.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Universal Technical Institute can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $134M | $66.5M | $152M | $162M | $127M |
| Debt incl. finance leases | $30.8M | $67.6M | $168M | $131M | $90.9M |
| Net debt / EBITDA | β3.6x | 0.0x | 0.4x | β0.4x | β0.3x |
| Debt / equity | 0.2x | 0.3x | 0.7x | 0.5x | 0.3x |
| Interest coverage | 41.0x | 11.2x | 2.2x | 6.2x | 14.8x |
| Current ratio | 1.4x | 1.0x | 1.1x | 1.1x | 1.1x |
| Quick ratio | 1.4x | 1.0x | 1.1x | 1.1x | 1.1x |
| Total assets | $513M | $553M | $741M | $745M | $826M |
| Total liabilities | $324M | $338M | $515M | $484M | $498M |
| Shareholders' equity | $189M | $215M | $226M | $260M | $328M |
| Net debt (β = net cash) | β$103M | $1.1M | $16.2M | β$31.4M | β$36.5M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.3M
1 insider
Sold, 12 months
$130M
6 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Robert Thomas DevincenziDirector | Bought | 1,000 | $19.68 | $0.0M | Form 4 |
| Sep 21, 2026 | Robert Thomas DevincenziDirector | Bought | 1,000 | $19.83 | $0.0M | Form 4 |
| Aug 27, 2026 | Robert Thomas DevincenziDirector | Bought | 1,000 | $21.80 | $0.0M | Form 4 |
| Aug 25, 2026 | Robert Thomas DevincenziDirector | Bought | 1,000 | $21.77 | $0.0M | Form 4 |
| Aug 12, 2026 | Robert Thomas DevincenziDirector | Bought | 1,000 | $25.95 | $0.0M | Form 4 |
| Aug 10, 2026 | Robert Thomas DevincenziDirector | Bought | 8,000 | $28.21 | $0.2M | Form 4 |
| Jun 29, 2026 | Jerome Alan GrantChief Executive Officer, Director | Sold | 94,500 | $41.40 | $3.9M | Form 4 |
| Jun 22, 2026 | Kevin PrehnConcorde Division President | Sold | 4,545 | $40.00 | $0.2M | Form 4 |
| Jun 8, 2026 | Coliseum Capital Partners L.p.Director | Sold | 3,000,000 | $41.40 | $124M | Form 4 |
| Jun 5, 2026 | Christine KlineSenior Vice President and CAO | Sold | 3,500 | $44.42 | $0.2M | Form 4 |
| May 11, 2026 | Linda J SrereDirector | Sold | 15,000 | $36.59 | $0.5M | Form 4 |
| Mar 27, 2026 | Christopher E. KevaneEVP and Chief Legal Officer | Sold | 23,654 | $37.55 | $0.9M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 8 | 5 / 8 | 6 / 8 |
| Accruals ratio | β5.7% | β5.9% | β4.4% |
| Altman Z'' | 0.86 | 1.41 | 1.91 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Universal Technical Institute UTI | $1.2B | 14.1% | 10.0% | 6.6% | 24.0% | 35.8x | 6 | |
| Perdoceo Education PRDO | $2.2B | 24.2% | 23.2% | 25.6% | β | 12.3x | β | Compare β |
| Coursera COUR | $1.2B | 9.0% | β10.2% | 14.2% | β | β | 5 | Compare β |
| Duolingo DUOL | $7.2B | 38.7% | 13.1% | 35.6% | 77.6% | 16.9x | 4 | Compare β |
| Grand Canyon Education LOPE | $4.3B | 7.1% | 24.0% | 21.6% | 45.3% | 19.8x | 4 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $347M | $324M | $317M | $332M | $301M | $335M | $419M | $607M | $733M | $836M |
| Operating income | β$18.6M | β$1.8M | β$35.3M | β$7.8M | β$3.9M | $14.9M | $22.4M | $21.4M | $58.9M | $83.5M |
| Interest expense | $3.4M | $3.4M | $3.3M | $3.2M | $0.0M | $0.4M | $2.0M | $9.7M | $9.5M | $5.6M |
| Pretax income | β$21.5M | β$2.7M | β$35.7M | β$7.7M | β$2.6M | $15.2M | $20.4M | $18.1M | $56.2M | $84.3M |
| Income tax | $26.2M | $5.4M | β$3.0M | $0.2M | β$10.6M | $0.6M | β$5.4M | $5.8M | $14.2M | $21.3M |
| Net income | β$47.7M | β$8.1M | β$32.7M | β$7.9M | $8.0M | $14.6M | $25.8M | $12.3M | $42.0M | $63.0M |
| Diluted EPS | β$2.02 | β$0.54 | β$1.51 | β$0.52 | $0.05 | $0.17 | $0.38 | $0.13 | $0.75 | $1.13 |
| Diluted shares | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B | 0.05B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $7.4M | $1.1M | β$13.4M | $21.7M | $11.0M | $55.2M | $46.0M | $49.1M | $85.9M | $97.3M |
| Capital expenditure | $7.5M | $8.2M | $20.6M | $6.5M | $9.3M | $61.3M | $79.5M | $56.7M | $24.3M | $42.0M |
| Free cash flow | β$0.1M | β$7.0M | β$34.0M | $15.3M | $1.8M | β$6.1M | β$33.4M | β$7.5M | $61.6M | $55.4M |
| Depreciation and amortization | $15.1M | $14.2M | $13.0M | $13.2M | $11.8M | $14.0M | $16.9M | $25.2M | $29.3M | $33.0M |
| Stock-based compensation | $4.9M | $2.9M | $1.8M | $1.4M | $2.1M | $1.7M | $4.3M | $3.8M | $8.6M | $9.2M |
| Acquisitions | $1.5M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $26.5M | $16.4M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $1.5M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $1.5M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $119M | $50.1M | $58.1M | $65.4M | $76.8M | $134M | $66.5M | $152M | $162M | $127M |
| Total debt | β | β | β | β | $0.3M | $30.7M | $67.5M | $162M | $126M | $87.1M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.3M | $0.1M | $0.0M | $5.6M | $4.8M | $3.8M |
| Current assets | $162M | $147M | $117M | $118M | $180M | $183M | $136M | $205M | $222M | $247M |
| Current liabilities | $94.6M | $86.4M | $92.5M | $96.8M | $122M | $133M | $138M | $185M | $205M | $230M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $114M | $107M | $115M | $104M | $72.7M | $122M | $214M | $266M | $265M | $286M |
| Total assets | $297M | $274M | $282M | $271M | $442M | $513M | $553M | $741M | $745M | $826M |
| Total liabilities | $161M | $148M | $156M | $156M | $266M | $324M | $338M | $515M | $484M | $498M |
| Shareholders' equity | $137M | $126M | $127M | $114M | $177M | $189M | $215M | $226M | $260M | $328M |
| Margins | ||||||||||
| Operating margin | β5.4% | β0.6% | β11.1% | β2.4% | β1.3% | 4.5% | 5.3% | 3.5% | 8.0% | 10.0% |
| EBITDA margin | β1.0% | 3.8% | β7.0% | 1.6% | 2.6% | 8.7% | 9.4% | 7.7% | 12.0% | 13.9% |
| Net margin | β13.7% | β2.5% | β10.3% | β2.4% | 2.7% | 4.4% | 6.2% | 2.0% | 5.7% | 7.5% |
| FCF margin | β0.0% | β2.2% | β10.7% | 4.6% | 0.6% | β1.8% | β8.0% | β1.2% | 8.4% | 6.6% |
| Returns | ||||||||||
| Return on capital | β | β | β | β | β | 15.5% | 14.8% | 6.4% | 18.7% | 24.0% |
| Return on capital employed | β9.8% | β0.9% | β18.7% | β4.3% | β1.6% | 4.3% | 5.6% | 4.4% | 10.8% | 14.7% |
| Return on equity | β38.1% | β6.2% | β25.9% | β6.5% | 5.5% | 8.0% | 12.8% | 5.6% | 17.3% | 21.4% |
| Return on assets | β16.7% | β2.9% | β11.8% | β2.9% | 2.3% | 3.1% | 4.9% | 1.9% | 5.7% | 8.0% |
| Growth | ||||||||||
| Revenue growth | β4.3% | β6.6% | β2.3% | 4.6% | β9.3% | 11.4% | 25.0% | 45.1% | 20.6% | 14.1% |
| Net income growth | β | β | β | β | β | 82.1% | 77.3% | β52.3% | 240.9% | 50.0% |
| EPS growth | β | β | β | β | β | 240.0% | 123.5% | β65.8% | 476.9% | 50.7% |
| FCF growth | β | β | β | β | β88.4% | β445.8% | β | β | β | β10.1% |
| Share count change | β0.3% | 1.6% | 1.6% | 1.3% | 18.4% | 10.0% | 1.9% | 2.2% | 47.5% | 9.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β | β9.6x | β3.6x | 0.0x | 0.4x | β0.4x | β0.3x |
| Debt / equity | β | β | β | β | 0.0x | 0.2x | 0.3x | 0.7x | 0.5x | 0.3x |
| Interest coverage | β5.4x | β0.5x | β10.7x | β2.4x | β387.1x | 41.0x | 11.2x | 2.2x | 6.2x | 14.8x |
| Current ratio | 1.7x | 1.7x | 1.3x | 1.2x | 1.5x | 1.4x | 1.0x | 1.1x | 1.1x | 1.1x |
| Quick ratio | 1.7x | 1.7x | 1.3x | 1.2x | 1.5x | 1.4x | 1.0x | 1.1x | 1.1x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.2% | 2.5% | 6.5% | 2.0% | 3.1% | 18.3% | 19.0% | 9.3% | 3.3% | 5.0% |
| Stock comp / revenue | 1.4% | 0.9% | 0.6% | 0.4% | 0.7% | 0.5% | 1.0% | 0.6% | 1.2% | 1.1% |
| Payouts / FCF | β | β | β | 0.0% | 0.0% | β | β | β | 0.0% | 0.0% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | β | β | 4.0 | 5.0 | 5.0 | 5.0 | 6.0 |
| Altman Z'' | 1.8 | 1.9 | 0.2 | 0.6 | 1.3 | 1.3 | 0.9 | 0.9 | 1.4 | 1.9 |
| Accruals ratio | β19.3% | β3.3% | β7.0% | β10.7% | β0.9% | β8.5% | β3.8% | β5.7% | β5.9% | β4.4% |
Source: SEC EDGAR XBRL filings (CIK 0001261654). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.